Atlas Trials

Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease

Clinical trial NCT05196958 · UNKNOWN

Trial details

NCT number
NCT05196958
Sponsor
Fondation Hôpital Saint-Joseph
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Inflammatory Bowel DiseasesDiabetes Mellitus, Type 2
Start date
2022-01-25
Primary completion
2024-01-14
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.